We recently found that intramyocardially administered Flt3 ligand (Flt3L) confers cytoprotection in the infarcted mouse heart, thereby reducing infarct size and improving post-myocardial infarction remodeling and function (Pfister et al, 2014). The gene discussed is FLT3LG; the disease is myocardial infarction.